R. Nogaylar

发表

Combined metabolic activators improve cognitive functions in Alzheimer’s disease patients: a randomised, double-blinded, placebo-controlled phase-II trial

J. Borén, M. Uhlén, A. Mardinoğlu, 2023, Translational neurodegeneration.

Combined Metabolic Activators Improves Cognitive Functions in Alzheimer's Disease

J. Borén, A. Mardinoğlu, M. Uhlén, 2021, medRxiv.

Combined Metabolic Activators Improve Cognitive Functions without Altering Motor Scores in Parkinson's Disease

J. Borén, A. Mardinoğlu, M. Uhlén, 2021, medRxiv.

Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases.

J. Borén, M. Uhlén, A. Mardinoğlu, 2022, Life sciences.